WO2019027693A1 - System for automatic and early detection of free flap failure - Google Patents
System for automatic and early detection of free flap failure Download PDFInfo
- Publication number
- WO2019027693A1 WO2019027693A1 PCT/US2018/042986 US2018042986W WO2019027693A1 WO 2019027693 A1 WO2019027693 A1 WO 2019027693A1 US 2018042986 W US2018042986 W US 2018042986W WO 2019027693 A1 WO2019027693 A1 WO 2019027693A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- circuitry
- features
- signal
- vbaseband
- vzcr
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/06—Measuring blood flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0002—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network
- A61B5/0004—Remote monitoring of patients using telemetry, e.g. transmission of vital signals via a communication network characterised by the type of physiological signal transmitted
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/725—Details of waveform analysis using specific filters therefor, e.g. Kalman or adaptive filters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7235—Details of waveform analysis
- A61B5/7264—Classification of physiological signals or data, e.g. using neural networks, statistical classifiers, expert systems or fuzzy systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/42—Details of probe positioning or probe attachment to the patient
- A61B8/4209—Details of probe positioning or probe attachment to the patient by using holders, e.g. positioning frames
- A61B8/4227—Details of probe positioning or probe attachment to the patient by using holders, e.g. positioning frames characterised by straps, belts, cuffs or braces
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/44—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device
- A61B8/4444—Constructional features of the ultrasonic, sonic or infrasonic diagnostic device related to the probe
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/488—Diagnostic techniques involving Doppler signals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
- A61B2560/02—Operational features
- A61B2560/0204—Operational features of power management
- A61B2560/0214—Operational features of power management of power generation or supply
- A61B2560/0219—Operational features of power management of power generation or supply of externally powered implanted units
Definitions
- the present invention relates to free flap surgery, and, in particular, to a system for automatic detection of early onset of the failure of a free flap after free flap surgery.
- a flap is a piece of tissue that is used to cover a wound.
- a free flap is a piece of tissue that is disconnected from its original blood supply and is moved to a different part of the body and reconnected to a new blood supply.
- the current gold standard for free flap monitoring is the Cook-Swartz Doppler Probe and System.
- the Cook-Swartz Doppler Probe and System is comprised of a bedside monitor, a probe that affixes to the monitored blood vessel, and a wire tether to connect the probe to the bedside monitor.
- the wire tether can be easil snagged, resulting in misalignment of the probe on the vessel and even total disconnection of the wire from the probe.
- a method of monitoring patency of a free flap connected to a blood supply including a blood vessel includes insonifying a blood flow volume within the blood vessel, receiving a scattered signal, the scattered signal being generated in response to the blood flow volume being insonified, extracting a baseband Doppler blood flow signal,
- VBASEBAND and classifying the plurality of features and generating a binary signal based on the classification of the plurality of features, wherein the binary signal will have a first state responsive to the classification of the plurality of features indicating that a flow rate within the blood vessel is less than a predetermined level and a second state responsive to the classification of the plurality of features indicating the flow rate within the blood vessel is greater than or equal to the predetermined level,
- FIG. 1 is a schematic diagram of a free flap patency monitoring system according to an exemplar ⁇ ' embodiment of the disclosed concept
- FIG. 2 is a schematic diagram of analog front end circuitry forming a part of the system of FIG. 1 according to one particular non-limiting exemplary embodiment of the disclosed concept;
- FIG. 3 is a schematic diagram of zero crossing feature extractor circuitry forming a part of the system of FIG. I according to one particular non- limiting exemplar ⁇ ' embodiment of the disclosed concept;
- FIG. 4 is a schematic diagram of energy feature extractor circuitry forming a part of the system of FIG. 1 according to one particular non-limiting exemplar ⁇ ' embodiment of the disclosed concept
- FIG. 5 is a schematic diagram of clock and timing management circuitry forming a part of the system of FIG. 1 according to one particular non- limiting exemplary embodiment of the disclosed concept;
- FIG. 6 is a schematic diagram of prior feature classification circuitry that may be used as a part of the system of FIG. 1 according to one particular non- limiting exemplar ⁇ - embodiment of the disclosed concept;
- FIG. 7 is a schematic diagram of alternative classification circuitry that may be used as a part of the system of FIG. 1 according to another particular non- limiting exemplary embodiment of the disclosed concept.
- directly coupled means that two elements are directly in contact with each other.
- number shall mean one or an integer greater than one (i.e., a plurality).
- the disclosed concept provides a system for automated free flap patency monitoring that eliminates the need for experienced personnel to participate in the decision-making process.
- the automated nature of the system and elimination of human interpretation will improve false positive rates
- the system of the disclosed concept employs feature extraction hardware/circuitry (in particular, zero-crossing and signal energy features) and classification/decision making hardware/circuitry (in particular, a two-dimensional dividing hyperplane) that makes the system particularly amenable to a microchip implementation wherein all of the blood flow information processing is performed in real time and on the implanted device, with the result being that only a simple "yes” or " no " status (i.e., a binary output) regarding free flap patency needs to be transmitted at the end of a measurement (e.g., at the end of a measurement window size/period as described herein).
- valuable radio frequency spectrum usage is significantly reduced as compared to devices that transmit digitized Doppler blood flow signals from the implante
- FIG. 1 is a schematic diagram of a free flap patency monitoring system 2 according to an exemplary embodiment of the disclosed concept.
- free flap patency monitoring system 2 is structured to determine the patency of a free flap connected to a blood supply including a blood vessel 4, which in the non-limiting exemplary embodiment is a vein, based upon the level of detected blood flow through blood vessel 4.
- free flap patency monitoring system 2 includes several individual hardware circuitry modules (the majority of which are analog) that are structured to cooperate to monitor free flap patency based on detected flow rates, in particular, the hardware circuitry modules provided as part of free flap patency monitoring system 2 include analog front end circuitry 6, zero crossing feature extractor circuitry 8, energy feature extractor circuitry 10, clock and timing management circuitry 12, feature classification circuitry 14, load modulation circuitry 16, and energy harvesting circuitry 18. Each of these hardware circuitry modules is described in greater below.
- free flap patency monitoring system 2 is a hardware-only implementation wherein the individual hardware circuitry modules are implemented as part of a monolithic microchip suitable for implantation in the body.
- free flap patency monitoring system 2 is implemented as a monolithic microchip that both receives power and communicates information wirelessly.
- analog front end circuitry 6 is coupled to a transmit piezoelectric transducer 20 and a receive piezoelectric transducer 22, Transmit piezoelectric transducer 20 and receive piezoelectric transducer 22 are inset to a cuff 24 that wraps around blood vessel 4.
- transmit piezoelectric transducer 20 and receive piezoelectric transducer 22 are configured in a classic continuous wave (CW) Doppier configuration as described in, for example, United States Patent No. 6,346,081.
- Analog front end circuitry 6 is structured to insonify the blood sample volume within blood vessel 4 using transmit piezoelectric transducer 20.
- analog front end circuitry 6 is coupled to both zero crossing feature extractor circuitry 8 and energy feature extractor circuitry 10, and the extracted VBASEBAND is provided to each of zero crossing feature extractor circuitry 8 and energy feature extractor circuitry 10.
- Zero crossing feature extractor circuitry 8 is structured to generate and output a continuous time signal, VZCR, which is a voltage signal that is a measure of the zero crossing rate of the raw baseband Doppier blood flow signal VBASEBAND. VZCR provides an estimate of the mean Doppier frequency of VBASEBAND.
- Energy feature extractor circuitry 10 is structured to generate and output a continuous time signal, VENERGY, which is a voltage signal that is a measure of the energy of the raw baseband Doppier blood flow signal VBASEBAND.
- VENERGY a voltage signal that is a measure of the energy of the raw baseband Doppier blood flow signal VBASEBAND.
- the maximum of VBASEBAND provides a reasonable estimate of signal energy during a predetermined window period.
- Zero crossing feature extractor circuitry 8 and energy feature extractor circuitry 10 are both coupled to clock and timing management circuitry 12, and, as seen in FIG. 1, VZCR and VENERGY are provided as inputs to clock and timing management circuitry 12.
- Clock and timing management circuitry 12 is structured to provide clock synthesis, signal sampling and synchronization of system events for free flap patency monitoring system 2.
- clock and timing management circuitry 12 is structured to sample the VZCR and VE ERGY (after a predefined period called the window size or window period) and generate a sampled VZCR signal, VZCR,SH , and a sampled VENERGY signal signal, VBNERGY,SH, which are both discrete time voltage signals (i.e., VZCR.SH and VENERGY,SH are each a time series of a sequence of sampled data from the continuous signals VZCR and VENERGY).
- VZCR.SH and VENERGY,SH are provided to feature
- Feature classification circuitry 14 is, in the non-limiting exemplar ⁇ ' embodiment, a monolithic decision circuit that implements a two- dimensional dividing hyperplane, where VZCR,SH and VENERGY.SH are classified as being on one side of the dividing hyperplane or the other.
- Feature classification circuitry 14 is structured to output a binary signal, VPATENCY, which, in the exemplary embodiment, is high when "flow" is detected as described herein and low when "no flow” is detected as described herein.
- FIG. 3 is a schematic diagram of zero crossing feature extractor circuitry 8 according to one particular non-limiting exemplary embodiment of the disclosed concept.
- Zero crossing feature extractor circuitry 8 is stmctured to detect negative-going (i.e., high-to-low) zero-crossings. To do this, first a comparator 36 toggles when any zero-crossing is detected. Comparator 36 drives a one-shot pulse generator 38, which is falling-edge triggered (i.e., sensitive only to negative-going zero-crossings). These one-shot pulses turn on a current source 40 (e.g., comprised of quad matched PMOS devices) that drives a current onto a sampling capacitor 42 for integration. The voltage on sampling capacitor 42 is processed by a voltage limiter and low-pass filter buffer 44 to confine the range of VZCR between 0V-3.3V. The VZCR voltage represents the VBASEBAND negative-going zero-crossings.
- a current source 40 e.g., comprised of quad matched PMOS
- FIG. 4 is a schematic diagram of energy feature extractor circuitry 10 according to one particular non-limiting exemplar ⁇ ' embodiment of the disclosed concept.
- Energy feature extractor circuitry 1 0 includes two op-amps 46 and 48, and a diode 50, a resistor 52, and a capacitor 54 located between the op-amps 46 and 48. These components form a peak detector that tracks the envel ope of the VBASEB AND signal.
- Op amp 48 and an op amp 56 perform a signal inversion and level-shift so that the envelope signal range sits between 0V-3.3V.
- a low-pass filter and buffer 58 follows, and its output is VENERGY.
- FIG. 5 is a schematic diagram of clock and timing management circuitry 12 according to one particular non-limiting exemplar)' embodiment of the disclosed concept.
- clock and timing management circuitr' 12 performs timing functions and distributes clocks/pulses throughout free flap patency monitoring system 2
- Clock and timing management circuitry 1 2 includes a clock generator 60 that generates a square-wave clock that drives a rising-edge one- shot pulse generator 62.
- Clock generator 60 sets the window period described herein (e.g., 50 ms).
- the output of one-shot pulse generator 62 is a pulse train of narrow- width pulses at a frequency equal to the frequency of clock generator 60.
- the output of one-shot pulse generator 62 also triggers sample/hold circuitry 64.
- Sample/hold circuitry 64 samples the continuous time VZCR and VENERGY signals for the duration of the narrow-width pulse, and the sampled signal is held constant, as VZCR.SH and VENERGY.SH, until another pulse triggers sample/hold circuitry 64, thus updating the VZCR.SH and VENERGY,SH voltages.
- the output of one-shot pulse generator 62 drives an edge-triggered waveform-delay integrated circuit (IC) 66, followed by a falling-edge triggered one-shot pulse generator 68.
- One-shot pulse generator 62 and edge-triggered waveform-delay IC 66 form a dead-time generator (i.e., the two pulse- widths are non-overlapping and have a small dead-time between the two pulses).
- the output of the one-shot pulse generator 68 is a time-delayed version of the narrow- width pulse train of one-shot pulse generator 62 .
- the output of one-shot pulse generator 68 drives the NMOS device in zero crossing feature extractor circuitry 8 (FIG. 3), which shunts current away from storage capacitor 42 to reduce its stored charge, thus resetting the storage capacitor voltage to VO; V0 is near the ground voltage potential in the exemplary embodiment. The reason for doing all of this is evident by considering that the voltage on the sampling capacitor 42 must be sampled before it is reset.
- the window period is the observation period over which features of the VBASEBAND signal are computed; at the end of the observation period, the feature voltages VZCR and VENERGY are sampled and held constant; VZCR and VENERGY are updated at the end of each observation peri od.
- the sample's amplitude voltage is held constant (i.e., only for the duration of the window period) and input into feature classification circuitry 14.
- the window size can be thought of as the observation time period (i.e., window) over which feature values are extracted. For example, if we have a 1.2 V 3 Hz signal (i.e., 1.2*cos[2*pi*3*t] ) and a 3 second window size, then the zero-crossing feature will be equal to 18 (i.e., 2 zero-crossings per cycle, and 3 cycles per second, times 3 seconds), and the energy feature will be equal to 1.2 V.
- the zero-crossing feature will be equal to 4, and the energy feature equal to 1.2 V.
- the present inventors have determined, however, that there is a diminishing return as window size is increased past approximately 50 ms.
- feature classification circuitry 14 is primarily comprised of transistors and a few resistors and capacitors. As described elsewhere herein, the sampled feature voltages, VZCR,SH and VENEP.GY.SH, drive this module. Feature classification circuitry 14 operates in continuous time, but it is effectively discrete-time because VZCR,SH and VENERGY,SH are discrete-time voltages. Feature classification circuitry 14 essentially creates a threshold, where that threshold is an "effective" hyperpiane line.
- feature classification circuitry 14 is similar to and may employ the classifier design 70 described in B, Gestner, et al, "Glass break detector analog front-end using novel classifier circuit," in 2007 IEEE International
- feature classification circuitry 14 may employ classifier design 80 shown in FIG. 7.
- Classifier design 80 is similar to classifier design 70.
- Classifier design 80 uses two features (i.e., the "ENERGY” and “ZCR” blocks in the figure), as well as two series resistors shown in the "ENERGY” and “ZCR” blocks to improve control over shaping the discriminating hyperplane line.
- the VENERGY,SH and VZCR.SH are the sampled VENERGY and VZCR voltages, respectively, as described herein.
- V ⁇ as,OFF is the bias voltage that controls the I 0 ff current which is described by Gestner et al.
- Vthres is described by Gestner et al.
- Vbias,ENERGY and Vbias,zcR control the current through the current mirror branches in the "ENERGY" and “ZCR” blocks.
- VPATENCY is the circuit's binary output estimate of blood vessel patency.
- the PMOS devices are ALD 1 107 and ALD1 117 matched transistor packages, and the NMOS devices are ALD1 106 and ALD1 1 16 matched transistor packages.
- a majority vote protocol is utilized and implemented in free flap patency monitoring system 2 in order to provide more accurate results.
- multiple windowed classification decisions as described herein are acquired for a period of time, such as, without limitation, one second or thirty seconds, and then a majority vote is used to determine the VPATENCY value (high or low) for that period.
- the majority vote based VPATENCY value for each period is transmitted by free flap patency monitoring system 2 as described herein for use by an individual, such as a clinician or other operator.
- free flap patency monitoring system 2 is provided with voting protocol circuitry that is structured to aggregate the VPATENCY decisions across the predetermined observation period (e.g., one or thirty seconds as noted above) and calculate and output the majority vote based VPATENCY value.
- voting protocol circuitry structured to aggregate the VPATENCY decisions across the predetermined observation period (e.g., one or thirty seconds as noted above) and calculate and output the majority vote based VPATENCY value.
- the disclosed concept provides a hardware-only free flap patency monitoring system that is capable of detecting flap failures before they happen, that provides a simple binary output indicator of free flap patency status, and that does not require any operator experience to interpret.
- any reference signs placed between parentheses shall not be construed as limiting the claim.
- the word “comprising ' " or “including” does not exclude the presence of elements or steps other than those listed in a claim.
- several of these means may be embodied by- one and the same item of hardware.
- the word “a” or “an” preceding an element does not exclude the presence of a plurality of such elements.
- any device claim enumerating several means several of these means may be embodied by one and the same item of hardware.
- the mere fact that certain elements are recited in mutually different dependent claims does not indicate that these elements cannot be used in combination.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Artificial Intelligence (AREA)
- Physiology (AREA)
- Signal Processing (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Psychiatry (AREA)
- Hematology (AREA)
- Evolutionary Computation (AREA)
- Fuzzy Systems (AREA)
- Mathematical Physics (AREA)
- Computer Networks & Wireless Communication (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
Abstract
A system for monitoring free flap patency includes transmit and receive transducers structured to be coupled to a blood vessel, and a plurality of circuitry modules structured to insonify a blood flow volume within the blood vessel and receive a scattered signal from the receive transducer, extract a baseband Doppler blood flow signal, VBASEBAND, from the scattered signal, extract a plurality of features from VBASEBAND, and classify the plurality of features and generate a binary signal based on the classification of the plurality of features, wherein the binary signal will have a first state responsive to the classification of the plurality of features indicating that a flow rate within the blood vessel is less than a predetermined level and a second state responsive to the classification of the plurality of features indicating the flow rate within the blood vessel is greater than or equal to the predetermined level.
Description
SYSTEM FOR AUTOMATIC AND EARLY
DETECTION OF FREE FLAP FAILURE
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority under 35 U.S.C. § 1 19(e) from U.S. provisional patent application no. 62/539,043, entitled "System for Automatic and Early Detection of Free Flap Failure" and filed on July 31, 2017, the contents of which are incorporated herein by reference.
B ACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to free flap surgery, and, in particular, to a system for automatic detection of early onset of the failure of a free flap after free flap surgery.
2. Description of the Related Art
A flap is a piece of tissue that is used to cover a wound. A free flap is a piece of tissue that is disconnected from its original blood supply and is moved to a different part of the body and reconnected to a new blood supply.
Hourly blood vessel patency monitoring in the first few days after free flap surgery is crucial to the survival of the free flap transferred tissue. Loss of flow, if not caught promptly, can result in loss of the free flap, amputation, and death. Up to 10% of free fl ap cases are compromi sed in the post-operative monitoring period.
The current gold standard for free flap monitoring is the Cook-Swartz Doppler Probe and System. The Cook-Swartz Doppler Probe and System is comprised of a bedside monitor, a probe that affixes to the monitored blood vessel, and a wire tether to connect the probe to the bedside monitor. The wire tether can be easil snagged, resulting in misalignment of the probe on the vessel and even total disconnection of the wire from the probe.
False positive rates with the Cook-Swartz Doppler Probe and System can be as high as 30%. False positives result in costly surgical re-exploration (as much as $20,000-$30,000 per incident). Another problem with the Cook-Swartz Doppler Probe and System is that it provides an audio output that requires human
interpretation in order to make a judgment as to free flap patency (i.e., blood flow or no blood flow).
Typically, the venous outflow of a free fl ap is a better indicator of free flap patency as compared to monitoring arterial flow. Thus, it is often the venous outflow of a free flap that is monitored using the Cook-Swartz Doppler Probe and System. Unfortunately, it is very difficult to distinguish the venous flow audio signature from background noise due to the similarity of the two signals/sources. As a result, experienced personnel are needed to make a judgment as to free flap patency (i.e., blood flow or no blood flow) using the Cook-Swartz Doppler Probe and System,
M. A, Rothfuss, et a!,, "A system for simple real-time anastomotic failure detection and wireless blood flow monitoring in the lower limbs," IEEE Journal / ' runsi ii im.1 E gi e ring In Health an Medicine, vol. 4, pp. 1-15, 2016, describes a wireless implantable patency monitor for peripheral veins that was developed by a number of the present inventors. The described monitor provides a visual output from which clinicians are able to determine venous patency. However, from a clinical and usability perspective, the described monitor has a number of shortcomings. First, the baseline flow must be recorded to determine future flow status, and an experienced clinician is still needed to interpret the output. In addition, the monitor requires a high power budget because it digitizes blood flow waveform signals and transmits the data wirelessly to an external receiver for processing.
SUMMARY OF THE INVENTION
In one embodiment, an implantable system for monitoring patency of a free flap connected to a blood supply including a blood vessel in provided. The system includes a transmit transducer structured to be coupled to the blood vessel, a receive transducer structured to be coupled to the blood vessel, and a plurality of circuitry modules coupled to the transmit transducer and the receive transducer, wherein the plurality of circuitry modules are structured to: insonify a blood flow volume within the blood vessel through the transmit transducer and receive a scattered signal from the receive transducer, the scattered signal being generated in response to the blood flow volume being insonified, extract a baseband Doppler blood flow
signal, VBASEBAND, from the scattered signal, extract a plurality of features from VBASEBAND, and classify the plurality of features and generate a binary signal based on the classification of the plurality of features, wherein the binary signal will have a first state responsive to the classification of the plurality of features indicating that a flow rate within the blood vessel is less than a predetermined level and a second state responsive to the classification of the plurality of features indicating the flow rate within the blood vessel is greater than or equal to the predetermined level.
In another embodiment, a method of monitoring patency of a free flap connected to a blood supply including a blood vessel is provided. The method includes insonifying a blood flow volume within the blood vessel, receiving a scattered signal, the scattered signal being generated in response to the blood flow volume being insonified, extracting a baseband Doppler blood flow signal,
VBASEBAND, from the scattered signal, extracting a plurality of features from
VBASEBAND, and classifying the plurality of features and generating a binary signal based on the classification of the plurality of features, wherein the binary signal will have a first state responsive to the classification of the plurality of features indicating that a flow rate within the blood vessel is less than a predetermined level and a second state responsive to the classification of the plurality of features indicating the flow rate within the blood vessel is greater than or equal to the predetermined level,
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a schematic diagram of a free flap patency monitoring system according to an exemplar}' embodiment of the disclosed concept;
FIG. 2 is a schematic diagram of analog front end circuitry forming a part of the system of FIG. 1 according to one particular non-limiting exemplary embodiment of the disclosed concept;
FIG. 3 is a schematic diagram of zero crossing feature extractor circuitry forming a part of the system of FIG. I according to one particular non- limiting exemplar}' embodiment of the disclosed concept;
FIG. 4 is a schematic diagram of energy feature extractor circuitry forming a part of the system of FIG. 1 according to one particular non-limiting exemplar}' embodiment of the disclosed concept;
FIG. 5 is a schematic diagram of clock and timing management circuitry forming a part of the system of FIG. 1 according to one particular non- limiting exemplary embodiment of the disclosed concept;
FIG. 6 is a schematic diagram of prior feature classification circuitry that may be used as a part of the system of FIG. 1 according to one particular non- limiting exemplar}- embodiment of the disclosed concept; and
FIG. 7 is a schematic diagram of alternative classification circuitry that may be used as a part of the system of FIG. 1 according to another particular non- limiting exemplary embodiment of the disclosed concept.
DETAILED DESCRIPTION OF EXEMPLARY EMBODIMENTS
As used herein, the singular form of "a", "an", and "the" include plural references unless the context clearly dictates otherwise.
As used herein, the statement that two or more parts or components are "coupled" shall mean that the parts are joined or operate together either directly or indirectly, i.e., through one or more intermediate parts or components, so long as a link occurs.
As used herein, "directly coupled" means that two elements are directly in contact with each other.
As used herein, the term "number" shall mean one or an integer greater than one (i.e., a plurality).
As used herein, the term "hardware-only circuitry module" shall mean an electrical circuit module that does not include any hardware components that are capable of executing software programs/routines/algorithms, i.e., a circuit module that includes only hardware components that are not capable of executing software program s/routi nes/ algorithms ,
Directional phrases used herein, such as, for example and without limitation, top, bottom, left, right, upper, lower, front, back, and derivatives thereof, relate to the orientation of the elements shown in the drawings and are not limiting upon the claims unless expressly recited therein.
The disclosed concept will now be described, for purposes of explanation, in connection with numerous specific details in order to provide a
thorough understanding of the subject innovation. It will be evident, however, that the disclosed concept can be practiced without these specific details without departing from the spirit and scope of this innovation.
As described in greater detail herein, the disclosed concept provides a system for automated free flap patency monitoring that eliminates the need for experienced personnel to participate in the decision-making process. The automated nature of the system and elimination of human interpretation will improve false positive rates, in addition, as discussed herein, the system of the disclosed concept employs feature extraction hardware/circuitry (in particular, zero-crossing and signal energy features) and classification/decision making hardware/circuitry (in particular, a two-dimensional dividing hyperplane) that makes the system particularly amenable to a microchip implementation wherein all of the blood flow information processing is performed in real time and on the implanted device, with the result being that only a simple "yes" or "no" status (i.e., a binary output) regarding free flap patency needs to be transmitted at the end of a measurement (e.g., at the end of a measurement window size/period as described herein). As a result, valuable radio frequency spectrum usage is significantly reduced as compared to devices that transmit digitized Doppler blood flow signals from the implanted device for subsequent analysis.
FIG. 1 is a schematic diagram of a free flap patency monitoring system 2 according to an exemplary embodiment of the disclosed concept. As described in detail herein, free flap patency monitoring system 2 is structured to determine the patency of a free flap connected to a blood supply including a blood vessel 4, which in the non-limiting exemplary embodiment is a vein, based upon the level of detected blood flow through blood vessel 4. In the exemplary embodiment, detected flow rates that are determined to be below a predetermined threshold flow rate level are deemed to be "no flow" and are considered a "positive" determination, meaning that the free flap is compromised (i.e., not viable), and detected flow rates that are determined to be greater than or equal to the predetermined threshold flow rate level are deemed to be "flow" and are considered a "negative" determination, meaning that the free flap is not compromised (i.e., viable). In the non-limiting exemplar}' embodiment, the predetermined threshold flow rate level is chosen to be 50% of a known baseline flow rate for the particular tissue in question, although it will be understood that other
predetermined threshold flow rate levels may also be employed within the scope of the disclosed concept. Importantly, the predetermined threshold flow rate level may be chosen so as to establish a critical intervention point during the monitoring of a free flap.
As seen in FIG. 1, free flap patency monitoring system 2 includes several individual hardware circuitry modules (the majority of which are analog) that are structured to cooperate to monitor free flap patency based on detected flow rates, in particular, the hardware circuitry modules provided as part of free flap patency monitoring system 2 include analog front end circuitry 6, zero crossing feature extractor circuitry 8, energy feature extractor circuitry 10, clock and timing management circuitry 12, feature classification circuitry 14, load modulation circuitry 16, and energy harvesting circuitry 18. Each of these hardware circuitry modules is described in greater below.
In the non-limiting illustrated exemplary embodiment, free flap patency monitoring system 2 is a hardware-only implementation wherein the individual hardware circuitry modules are implemented as part of a monolithic microchip suitable for implantation in the body. In addition, in the non-limiting exemplary embodiment, and as described in more detail herein, free flap patency monitoring system 2 is implemented as a monolithic microchip that both receives power and communicates information wirelessly.
Referring to FIG. 1 , analog front end circuitry 6 is coupled to a transmit piezoelectric transducer 20 and a receive piezoelectric transducer 22, Transmit piezoelectric transducer 20 and receive piezoelectric transducer 22 are inset to a cuff 24 that wraps around blood vessel 4. In addition, in the exemplary embodiment, transmit piezoelectric transducer 20 and receive piezoelectric transducer 22 are configured in a classic continuous wave (CW) Doppier configuration as described in, for example, United States Patent No. 6,346,081. Analog front end circuitry 6 is structured to insonify the blood sample volume within blood vessel 4 using transmit piezoelectric transducer 20. Receive piezoelectric transducer 22 is structured to transduce the scattered signal that is generated as a result of the insonification of the blood sample volume within blood vessel 4, The transduced scattered signal is provided to analog front end circuitry 6, which in turn extracts the
baseband Doppier blood flow signal, VBASEBAND, from the scattered signal. As is known, VBASEBAND will have a frequency that is proportional to the velocity of the red blood cells (RBCs) in the blood sample volume within blood vessel 4 (RBCs are the piiman,' scatterers/reflectors in blood because such a large portion of the blood volume is RBCs). In particular, it is known that the insonifying acoustic wave that is output by transmit piezoelectric transducer 20 and that impinges on the RBCs within the blood sample volume within blood vessel 4 will scatter isotropically with an intensity proportional to f4 (i.e., Rayeligh scattering), so long as the wavelength of the wave is much larger than the RBCs and RBC aggregates. In addition, it is further known that the energy will be scattered at a frequency proportional to the velocity of the RBCs. The baseband Doppier signal may be extracted from the scattered signal in analog front end circuitry 6 using a zero-intermediate frequency (IF) mixer, where the resulting signal's frequency content represents the velocity of the RBCs, The Doppier frequency, j¾ which is proportional to the velocity of the RBCs is defined by the well- known Doppier equation.
As seen in FIG. 1, analog front end circuitry 6 is coupled to both zero crossing feature extractor circuitry 8 and energy feature extractor circuitry 10, and the extracted VBASEBAND is provided to each of zero crossing feature extractor circuitry 8 and energy feature extractor circuitry 10. Zero crossing feature extractor circuitry 8 is structured to generate and output a continuous time signal, VZCR, which is a voltage signal that is a measure of the zero crossing rate of the raw baseband Doppier blood flow signal VBASEBAND. VZCR provides an estimate of the mean Doppier frequency of VBASEBAND. Energy feature extractor circuitry 10 is structured to generate and output a continuous time signal, VENERGY, which is a voltage signal that is a measure of the energy of the raw baseband Doppier blood flow signal VBASEBAND. In the exemplary embodiment, the maximum of VBASEBAND provides a reasonable estimate of signal energy during a predetermined window period.
Zero crossing feature extractor circuitry 8 and energy feature extractor circuitry 10 are both coupled to clock and timing management circuitry 12, and, as seen in FIG. 1, VZCR and VENERGY are provided as inputs to clock and timing management circuitry 12. Clock and timing management circuitry 12 is structured to provide clock synthesis, signal sampling and synchronization of system events for free
flap patency monitoring system 2. With regard to signal sampling, clock and timing management circuitry 12 is structured to sample the VZCR and VE ERGY (after a predefined period called the window size or window period) and generate a sampled VZCR signal, VZCR,SH , and a sampled VENERGY signal signal, VBNERGY,SH, which are both discrete time voltage signals (i.e., VZCR.SH and VENERGY,SH are each a time series of a sequence of sampled data from the continuous signals VZCR and VENERGY).
[32] As seen in FIG. 1, VZCR.SH and VENERGY,SH are provided to feature
classification circuitry 14. Feature classification circuitry 14 is, in the non-limiting exemplar}' embodiment, a monolithic decision circuit that implements a two- dimensional dividing hyperplane, where VZCR,SH and VENERGY.SH are classified as being on one side of the dividing hyperplane or the other. Feature classification circuitry 14 is structured to output a binary signal, VPATENCY, which, in the exemplary embodiment, is high when "flow" is detected as described herein and low when "no flow" is detected as described herein. In other words, in the exemplary embodiment, a high VPATENCY signal indicates that the free flap is viable and not compromised (no surgeiy is needed) and a low VPATENCY signal indicates that the free flap is not viable and instead is compromised (surgery is needed).
[33] As noted elsewhere herein, in the non-limiting exemplary embodiment, free flap patency monitoring system 2 is structured to be powered wirelessly and communicate information wirelessly. More specifically, with respect to wireless information communication, free flap patency monitoring system 2 is structured to be able to wirelessly transmit the VPATENCY signal outside of the body of the patient so that it can be used by an individual, such as a clinician, to assess the patency of the free flap in question. For this purpose, free flap patency monitoring system 2 includes load modulation circuitry 16 and energy harvesting circuitry 18, both of which are coupled to an antenna 26, such as, without limitation, a dipole antenna. Energy harvesting circuitry 20 is structured to receive RF energy from an external source, such as an RFID reader device, and harvest energy therefrom by converting (i.e., rectifying) the received RF energy into DC energy, e.g., a DC voltage. The DC energy- is then used to power the circuitry of free flap patency monitoring system 2.
Furthermore, in the exemplary embodiment, load modulation circuitry 16 is coupled to feature classification circuitry and receives the VPATENCY signal. Load modulation
circuitry 16 is structured to modulate the RF carrier signal sent from the external source, such as an RFID reader device, in order to communicate the VPATENCY signal to the external source. In this exemplary implementation, the external source is thus able to "observe" the VPATENCY signal based on "load modulation." One particular manner in which such a wireless communication and power system may be implemented is described in detail in U.S. provisional patent application no.
62/336,897, entitled "Touch Probe Passively Powered Wireless Stent Antenna for Implanted Sensor Powering and Interrogation" and in PCX International Application No. PCT/US2017/03 1237, entitled "Touch Probe Passively Powered Wireless Stent Antenna for Implanted Sensor Powering and Interrogation" both of which are owned by the assignee of the disclosed concept. The disclosures of these applications are incorporated herein by reference.
It will be understood, however, that the just described wireless power and communication implementation is meant to be exemplary only and that other wireless power and communication implementations may also be employed within the scope of the disclosed concept. Moreover, it will be further understood that the disclosed concept is not limited to wirelessly powered implementations. Rather, the disclosed concept may also be implemented in connection with embodiments that employ on board storage such as an onboard battery (e.g., a rechargeable batter}').
FIG. 2 is a schematic diagram of analog front end circuitry 6 according to one particular non-limiting exemplar}' embodiment of the disclosed concept. In analog front end circuitry 6, transmit piezoelectric transducer 20 and receive piezoelectric transducer 22 are in a continuous wave (CW) configuration and are inset to cuff 24. Transmit piezoelectric transducer 20 is driven from a high-power high- frequency source (e.g., 500 microwatts) at the resonant frequency of transmit piezoelectric transducer 20 (e.g., 20 MHz). Transmit piezoelectric transducer 20 converts the electrical 20 MHz 500 microwatt signal into an ultrasonic acoustic wave that insonifies the blood flowing in blood vessel 4 (FIG. 1). The insonifying wave is scattered at a frequency deviation, from 20 MHz, proportional to the velocity of the red blood cells within the blood (i.e., the Doppier equation). The scattered acoustic wave is transduced by receive piezoelectric transducer 22 to a very low amplitude electrical signal. This low amplitude signal from receive piezoelectric transducer 22
drives the input of a low-noise amplifier (LNA) 28, which then drives a doubly balanced mixer 30, which then drives an intermediate frequency (IF) amplifier 32, which then drives a programmable low-pass filter 34. The output of low-pass filter 34 is VBASBBAND, which, as described elsewhere herein, is the raw baseband Doppler blood fl ow signal . VBASEBAND is comprised of the spatial average of the frequency deviations (i.e., proportional to velocity) of the red blood cells within the insonifying volume. As described elsewhere herein, VBASEBAND drives both of the feature extraction modules, zero crossing feature extractor circuitry 8 and energy feature extractor circuitry 10. The VBASEBAND signal resides, conveniently, in the audible range of human hearing (e.g., the VBASEBAND signal upper bandwidth limit may be about 8 kHz, with the human hearing upper bandwidth limit being about 20 kHz.),
FIG. 3 is a schematic diagram of zero crossing feature extractor circuitry 8 according to one particular non-limiting exemplary embodiment of the disclosed concept. Zero crossing feature extractor circuitry 8 is stmctured to detect negative-going (i.e., high-to-low) zero-crossings. To do this, first a comparator 36 toggles when any zero-crossing is detected. Comparator 36 drives a one-shot pulse generator 38, which is falling-edge triggered (i.e., sensitive only to negative-going zero-crossings). These one-shot pulses turn on a current source 40 (e.g., comprised of quad matched PMOS devices) that drives a current onto a sampling capacitor 42 for integration. The voltage on sampling capacitor 42 is processed by a voltage limiter and low-pass filter buffer 44 to confine the range of VZCR between 0V-3.3V. The VZCR voltage represents the VBASEBAND negative-going zero-crossings.
FIG. 4 is a schematic diagram of energy feature extractor circuitry 10 according to one particular non-limiting exemplar}' embodiment of the disclosed concept. Energy feature extractor circuitry 1 0 includes two op-amps 46 and 48, and a diode 50, a resistor 52, and a capacitor 54 located between the op-amps 46 and 48. These components form a peak detector that tracks the envel ope of the VBASEB AND signal. Op amp 48 and an op amp 56 perform a signal inversion and level-shift so that the envelope signal range sits between 0V-3.3V. A low-pass filter and buffer 58 follows, and its output is VENERGY.
FIG. 5 is a schematic diagram of clock and timing management circuitry 12 according to one particular non-limiting exemplar)' embodiment of the
disclosed concept. As noted elsewhere herein, clock and timing management circuitr' 12 performs timing functions and distributes clocks/pulses throughout free flap patency monitoring system 2, Clock and timing management circuitry 1 2 includes a clock generator 60 that generates a square-wave clock that drives a rising-edge one- shot pulse generator 62. Clock generator 60 sets the window period described herein (e.g., 50 ms). The output of one-shot pulse generator 62 is a pulse train of narrow- width pulses at a frequency equal to the frequency of clock generator 60. The output of one-shot pulse generator 62 also triggers sample/hold circuitry 64. Sample/hold circuitry 64 samples the continuous time VZCR and VENERGY signals for the duration of the narrow-width pulse, and the sampled signal is held constant, as VZCR.SH and VENERGY.SH, until another pulse triggers sample/hold circuitry 64, thus updating the VZCR.SH and VENERGY,SH voltages. Next, the output of one-shot pulse generator 62 drives an edge-triggered waveform-delay integrated circuit (IC) 66, followed by a falling-edge triggered one-shot pulse generator 68. One-shot pulse generator 62 and edge-triggered waveform-delay IC 66 form a dead-time generator (i.e., the two pulse- widths are non-overlapping and have a small dead-time between the two pulses). Thus, the output of the one-shot pulse generator 68 is a time-delayed version of the narrow- width pulse train of one-shot pulse generator 62 . The output of one-shot pulse generator 68 , VreSet, drives the NMOS device in zero crossing feature extractor circuitry 8 (FIG. 3), which shunts current away from storage capacitor 42 to reduce its stored charge, thus resetting the storage capacitor voltage to VO; V0 is near the ground voltage potential in the exemplary embodiment. The reason for doing all of this is evident by considering that the voltage on the sampling capacitor 42 must be sampled before it is reset. The reason for the reset in zero crossing feature extractor circuitry 8 and not energy feature extractor circuitry 10 is that zero crossing feature extractor circuitry 8 uses a storage element that integrates charge; whereas, the peak detector's output voltage in energy feature extractor circuitry 0 quickly decays to the instantaneous amplitude of VBASEBAND. Putting this all together, in the exemplary embodiment, the window period is the observation period over which features of the VBASEBAND signal are computed; at the end of the observation period, the feature voltages VZCR and VENERGY are sampled and held constant; VZCR and VENERGY are updated at the end of each observation peri od.
In the non-limiting exemplary embodiment, when each of VZCR and VENERGY is sampled, the sample's amplitude voltage is held constant (i.e., only for the duration of the window period) and input into feature classification circuitry 14. The window size can be thought of as the observation time period (i.e., window) over which feature values are extracted. For example, if we have a 1.2 V 3 Hz signal (i.e., 1.2*cos[2*pi*3*t] ) and a 3 second window size, then the zero-crossing feature will be equal to 18 (i.e., 2 zero-crossings per cycle, and 3 cycles per second, times 3 seconds), and the energy feature will be equal to 1.2 V. If the window were to be changed to 600 ms, the zero-crossing feature will be equal to 4, and the energy feature equal to 1.2 V. With regard to processing blood flow signal data, as window size is increased, the favorable results of improved sensitivity and specificity and false- positive rate are achieved. The present inventors have determined, however, that there is a diminishing return as window size is increased past approximately 50 ms.
In the exemplary embodiment, feature classification circuitry 14 is primarily comprised of transistors and a few resistors and capacitors. As described elsewhere herein, the sampled feature voltages, VZCR,SH and VENEP.GY.SH, drive this module. Feature classification circuitry 14 operates in continuous time, but it is effectively discrete-time because VZCR,SH and VENERGY,SH are discrete-time voltages. Feature classification circuitry 14 essentially creates a threshold, where that threshold is an "effective" hyperpiane line. The term "effective" is used because if you sweep the entire range of possible VZCR,SH and VENERGY,SH values that can be input to the hyperpiane circuit, you will find that on one side of this "effective" line, the VPATENCY value is low and on the other side of the line the VPATENCY value is high. In the exemplar}' embodiment, feature classification circuitry 14 is similar to and may employ the classifier design 70 described in B, Gestner, et al, "Glass break detector analog front-end using novel classifier circuit," in 2007 IEEE International
Symposium on Circuits and Systems, IEEE, 2007, pp. 3586-3589, which is shown in FIG. 6.
In an alternative embodiment, feature classification circuitry 14 may employ classifier design 80 shown in FIG. 7. Classifier design 80 is similar to classifier design 70. Classifier design 80 uses two features (i.e., the "ENERGY" and "ZCR" blocks in the figure), as well as two series resistors shown in the "ENERGY"
and "ZCR" blocks to improve control over shaping the discriminating hyperplane line. The VENERGY,SH and VZCR.SH are the sampled VENERGY and VZCR voltages, respectively, as described herein. V <as,OFF is the bias voltage that controls the I0ff current which is described by Gestner et al. Vthres is described by Gestner et al. and relates to control of the discriminating hyperplane line. Vbias,ENERGY and Vbias,zcR control the current through the current mirror branches in the "ENERGY" and "ZCR" blocks. VPATENCY is the circuit's binary output estimate of blood vessel patency. The PMOS devices are ALD 1 107 and ALD1 117 matched transistor packages, and the NMOS devices are ALD1 106 and ALD1 1 16 matched transistor packages.
In one particular exemplary embodiment, a majority vote protocol is utilized and implemented in free flap patency monitoring system 2 in order to provide more accurate results. In particular, in such an implementation, multiple windowed classification decisions as described herein are acquired for a period of time, such as, without limitation, one second or thirty seconds, and then a majority vote is used to determine the VPATENCY value (high or low) for that period. The majority vote based VPATENCY value for each period is transmitted by free flap patency monitoring system 2 as described herein for use by an individual, such as a clinician or other operator. In the exemplary embodiment, free flap patency monitoring system 2 is provided with voting protocol circuitry that is structured to aggregate the VPATENCY decisions across the predetermined observation period (e.g., one or thirty seconds as noted above) and calculate and output the majority vote based VPATENCY value.
Thus, as described in detail herein in various particular embodiments, the disclosed concept provides a hardware-only free flap patency monitoring system that is capable of detecting flap failures before they happen, that provides a simple binary output indicator of free flap patency status, and that does not require any operator experience to interpret.
In the claims, any reference signs placed between parentheses shall not be construed as limiting the claim. The word "comprising'" or "including" does not exclude the presence of elements or steps other than those listed in a claim. In a device claim enumerating several means, several of these means may be embodied by- one and the same item of hardware. The word "a" or "an" preceding an element does not exclude the presence of a plurality of such elements. In any device claim
enumerating several means, several of these means may be embodied by one and the same item of hardware. The mere fact that certain elements are recited in mutually different dependent claims does not indicate that these elements cannot be used in combination.
Although the invention has been described in detail for the purpose of illustration based on what is currently considered to be the most practical and preferred embodiments, it is to be understood that such detail is solely for that purpose and that the invention is not limited to the disclosed embodiments, but, on the contrary, is intended to cover modifications and equivalent arrangements that are within the spirit and scope of the appended claims. For example, it i s to be understood that the present invention contemplates that, to the extent possible, one or more features of any embodiment can be combined with one or more features of any other embodiment.
Claims
1 . An implantable system for monitoring patency of a free flap connected to a blood supply including a blood vessel, comprising:
a transmit transducer structured to be coupled to the blood vessel, a receive transducer structured to be coupled to the blood vessel; and a plurality of circuitry modules coupled to the transmit transducer and the receive transducer, wherein the plurality of circuitry modules are structured to:
insonify a blood flow volume within the blood vessel through the transmit transducer and receive a scattered signal from the receive transducer, the scattered signal being generated in response to the blood flow volume being in sonified,
extract a baseband Doppler blood flow signal, VBASEBAND, from the scattered signal,
extract a plurality of features from VBASEBAND, and
classify the plurality of features and generate a binary signal based on the classification of the plurality of features, wherein the binary signal will have a first state responsive to the classification of the plurality of features indicating that a flow rate within the blood vessel is less than a predetermined level and a second state responsive to the classification of the plurality of features indicating the flow rate within the blood vessel is greater than or equal to the predetermined level,
2. The system according to claim 1, wherein the plurality of circuitry modules are a plurality of hardware-only circuitry modules.
3. The system according to claim 2, wherein the plurality of hardware- only circuitry modules include:
analog front end circuitry coupled to the transmit transducer and the receive transducer, wherein the analog front end circuitry is stractured to insonify the blood flow volume within the blood vessel through the transmit transducer and receive the scattered signal from the receive transducer, and wherein the analog front end circuitry is structured to extract VBASEBAND,
zero crossing feature extractor circuitry coupled to the analog front end circuitry, wherein the zero crossing feature extractor circuitry is structured to receive VBASEBA D from the analog front end circuitry and generate, for a predetermined window period, a first voltage signal, VZCR, based on VBASEBAND that is a measure of a zero crossing rate of VBASEBAND and that comprises a first one of the plurality of features,
energy feature extractor circuitry coupled to the analog front end circuitry, wherein the energy feature extractor circuitry is structured to receive VBASEBAND from the analog front end circuitr' and generate, for the predetermined window period, a second voltage signal, VENERGY, based on VBASEBAND that is a measure of an energy of VBASEBAND and that comprises a second one of the plurality of features;
signal sampling circuitry coupled to the zero crossing feature extractor circuitry and the energy feature extractor circuitry, wherein the signal sampling circuitry is structured to receive VZCR and generate a first sampled signal, VZCR,SH, from VZCR and to receive VENERGY and generate a second sampled signal, VENERGY.SH, from VENERGY; and
feature classification circuitry coupled to the signal sampling circuitry, wherein the feature classification circuitr' is stmctured to classify the plurality of features and generate the binary signal based on at least VzcR.SH and VENERGY.SH.
4. The system according to claim 3, wherein the feature classification circuitry implements a two-dimensional dividing hyperplane where VZCR.SH and VENERGY,SH are classified as being on one side of the dividing hyperplane or the other.
5. The system according to claim 3, wherein the plurality of hardware- only circuitry modules are structured to implement a voting protocol to generate the binary signal based on VZCR.SH and VENERGY.SH and a number of additional sampled signals generated from VBASEBAND during a predetermined time period,
6. The system according to claim 1, wherein the system is structured to be powered wirelessly from a source external to the system,
7. The system according to claim 6, wherein the system further includes an antenna and energy harvesting circuitry coupled to the antenna, wherein the antenna is structured to receive RF energy and provide the RF energy to the energy harvesting circuitry, and wherein the energy harvesting circuitry is structured to generate DC power from the RF energy for powering the system.
8. The system according to claim 1, wherein the system further includes wireless communication circuitry for wirelessly transmitting the binary signal from the system.
9. The system according to claim 1 , further comprising a cuff structured to wrap around the blood vessel, wherein the transmit transducer and the receive transducer are attached to the cuff.
10. The system according to claim 1, wherein the transmit transducer and the receive transducer are each a piezoelectric transducer.
1 1. A method of monitoring patency of a free flap connected to a blood supply including a blood vessel, comprising:
insonifying a blood flow volume within the blood vessel; receiving a scattered signal, the scattered signal being generated in response to the blood flow volume being insonified;
extracting a baseband Doppler blood flow signal, VBASEBAND, from the scattered signal;
extracting a plurality of features from VBASEBAN;, and
classifying the plurality of features and generating a binary signal based on the classification of the plurality of features, wherein the binary signal will have a first state responsive to the classification of the plurality of features indicating that a flow rate within the blood vessel is less than a predetermined level and a second state responsive to the classification of the plurality of features indicating the flow rate within the blood vessel is greater than or equal to the predetermined level.
12. The method according to claim 1 1, wherein at least the extracting the baseband Doppler blood flow signal, VBASEBAND, the extracting the plurality of features from VBASEBAND, the classifying the plurality of features, and the generating the binary signal are performed within a plurality of hardware-only circuitry modules implanted within a patient,
13. The method according to claim 11, wherein the extracting the plurality of features from VBASEBAND comprises generating, for a predetermined window period, a first voltage signal, VZCR, based on VBASEBAND that is a measure of a zero crossing rate of VBASEBAND and that comprises a first one of the plurality of features and generating, for the predetermined window period, a second voltage signal, VENERGY, based on VBASEB AND that is a measure of an energy of VBASEBAND and that comprises a second one of the plurality of features, and wherein the classifying the plurality of features and the generating the binary signal comprises generating a first sampled signal, VZCR,SH, from VZCR, generating a second sampled signal, VENERGY,SH, from VENERGY, and classifying the plurality of features and generating the binary signal based on at least VZCR,SH and VENERGY,SH.
14. The method according to claim 11, wherein the classifying the plurality of features and generating the binary signal based on at least VZCR,SH and VENERGY.SH employs a two-dimensional dividing hyperplane where VZCR.SH and VENERGY.SH are classifi ed as being on one side of the dividing hyperplane or the other,
15. The method according to claim 11, wherein the classifying the plurality of features and generating the binary signal based on at least VZCR,SH and VENERGY.SH employs a voting protocol to generate the binary signal based on VZCR,SH and
VENERGY.SH and a number of additional sampled signals generated from VBASEBAND during a predetermined time period.
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/630,964 US11877885B2 (en) | 2017-07-31 | 2018-07-20 | System for automatic and early detection flap failure |
| US18/484,624 US20240041422A1 (en) | 2017-07-31 | 2023-10-11 | System for automatic and early detection of free flap failure |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762539043P | 2017-07-31 | 2017-07-31 | |
| US62/539,043 | 2017-07-31 |
Related Child Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US16/630,964 A-371-Of-International US11877885B2 (en) | 2017-07-31 | 2018-07-20 | System for automatic and early detection flap failure |
| US18/484,624 Continuation US20240041422A1 (en) | 2017-07-31 | 2023-10-11 | System for automatic and early detection of free flap failure |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2019027693A1 true WO2019027693A1 (en) | 2019-02-07 |
Family
ID=65233068
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2018/042986 Ceased WO2019027693A1 (en) | 2017-07-31 | 2018-07-20 | System for automatic and early detection of free flap failure |
Country Status (2)
| Country | Link |
|---|---|
| US (2) | US11877885B2 (en) |
| WO (1) | WO2019027693A1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210015674A (en) * | 2019-07-31 | 2021-02-10 | 가톨릭대학교 산학협력단 | Monitoring system for free flap |
| KR20210092239A (en) * | 2018-11-15 | 2021-07-23 | 백스터 인터내셔널 인코포레이티드 | blood vessel monitoring system |
Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6278890B1 (en) * | 1998-11-09 | 2001-08-21 | Medacoustics, Inc. | Non-invasive turbulent blood flow imaging system |
| US20040082868A1 (en) * | 2002-10-24 | 2004-04-29 | Campbell Michael K. | Device and method for vascular monitoring |
| US20050070799A1 (en) * | 2003-09-29 | 2005-03-31 | David Vilkomerson | Vessel flow monitoring system and method |
| US20100145210A1 (en) * | 2006-06-26 | 2010-06-10 | Claus Graff | Multi parametric classification of cardiovascular sounds |
| US20120009612A1 (en) * | 2009-05-04 | 2012-01-12 | Sitzman Thomas J | Method to detect and monitor compartment syndrome |
| US20120101381A1 (en) * | 2010-10-21 | 2012-04-26 | Palti Yoram Prof | Measuring pulmonary blood pressure using transthoracic pulmonary doppler ultrasound |
| US20130116575A1 (en) * | 2011-11-04 | 2013-05-09 | Marlin Mickle | Implantable doppler blood flow monitor and doppler probe |
| US20150063575A1 (en) * | 2013-08-28 | 2015-03-05 | Texas Instruments Incorporated | Acoustic Sound Signature Detection Based on Sparse Features |
| US20160100790A1 (en) * | 2014-10-08 | 2016-04-14 | Revealix, Inc. | Automated systems and methods for skin assessment and early detection of a latent pathogenic bio-signal anomaly |
| US20160135917A1 (en) * | 2013-05-15 | 2016-05-19 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Powering and reading implanted devices |
| WO2017115104A1 (en) * | 2015-12-28 | 2017-07-06 | B-K Medical Aps | High resolution compound ultrasound flow imaging |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4752843A (en) * | 1985-10-21 | 1988-06-21 | Gold Star Co., Ltd. | System for indicating a precise tracking in a video cassette recorder |
| US4802024A (en) * | 1986-11-12 | 1989-01-31 | Eastman Kodak Company | Video reproduction apparatus having automatic black and white calibration |
| CA2505416A1 (en) * | 2002-11-21 | 2004-06-10 | Wyeth | Methods for diagnosing rcc and other solid tumors |
| JP6527704B2 (en) * | 2015-01-29 | 2019-06-05 | ルネサスエレクトロニクス株式会社 | Semiconductor device |
-
2018
- 2018-07-20 WO PCT/US2018/042986 patent/WO2019027693A1/en not_active Ceased
- 2018-07-20 US US16/630,964 patent/US11877885B2/en active Active
-
2023
- 2023-10-11 US US18/484,624 patent/US20240041422A1/en active Pending
Patent Citations (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6278890B1 (en) * | 1998-11-09 | 2001-08-21 | Medacoustics, Inc. | Non-invasive turbulent blood flow imaging system |
| US20040082868A1 (en) * | 2002-10-24 | 2004-04-29 | Campbell Michael K. | Device and method for vascular monitoring |
| US20050070799A1 (en) * | 2003-09-29 | 2005-03-31 | David Vilkomerson | Vessel flow monitoring system and method |
| US20100145210A1 (en) * | 2006-06-26 | 2010-06-10 | Claus Graff | Multi parametric classification of cardiovascular sounds |
| US20120009612A1 (en) * | 2009-05-04 | 2012-01-12 | Sitzman Thomas J | Method to detect and monitor compartment syndrome |
| US20120101381A1 (en) * | 2010-10-21 | 2012-04-26 | Palti Yoram Prof | Measuring pulmonary blood pressure using transthoracic pulmonary doppler ultrasound |
| US20130116575A1 (en) * | 2011-11-04 | 2013-05-09 | Marlin Mickle | Implantable doppler blood flow monitor and doppler probe |
| US20160135917A1 (en) * | 2013-05-15 | 2016-05-19 | University Of Pittsburgh-Of The Commonwealth System Of Higher Education | Powering and reading implanted devices |
| US20150063575A1 (en) * | 2013-08-28 | 2015-03-05 | Texas Instruments Incorporated | Acoustic Sound Signature Detection Based on Sparse Features |
| US20160100790A1 (en) * | 2014-10-08 | 2016-04-14 | Revealix, Inc. | Automated systems and methods for skin assessment and early detection of a latent pathogenic bio-signal anomaly |
| WO2017115104A1 (en) * | 2015-12-28 | 2017-07-06 | B-K Medical Aps | High resolution compound ultrasound flow imaging |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20210092239A (en) * | 2018-11-15 | 2021-07-23 | 백스터 인터내셔널 인코포레이티드 | blood vessel monitoring system |
| KR102688400B1 (en) | 2018-11-15 | 2024-07-29 | 백스터 인터내셔널 인코포레이티드 | vascular monitoring system |
| KR20210015674A (en) * | 2019-07-31 | 2021-02-10 | 가톨릭대학교 산학협력단 | Monitoring system for free flap |
| KR102446153B1 (en) * | 2019-07-31 | 2022-09-23 | 가톨릭대학교 산학협력단 | Skin-attached glass flap blood flow monitoring system |
Also Published As
| Publication number | Publication date |
|---|---|
| US11877885B2 (en) | 2024-01-23 |
| US20240041422A1 (en) | 2024-02-08 |
| US20200222026A1 (en) | 2020-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20240041422A1 (en) | System for automatic and early detection of free flap failure | |
| US8290577B2 (en) | Methods and apparatus for enhanced fiducial point determination and non-invasive hemodynamic parameter determination | |
| US10537403B2 (en) | Passive RFID based health data monitor | |
| JP6574521B2 (en) | Apparatus and method for determining fetal heart rate | |
| US20170049339A1 (en) | Mobile System For Comprehensive Medical Examination | |
| CN105496462B (en) | Fetal rhythm localization method and device | |
| US20150164417A1 (en) | Medical radar system for guiding cardiac resuscitation | |
| US20080287788A1 (en) | Systems and methods for organ monitoring | |
| GB2420628A (en) | Two-part template matching ECG monitor | |
| EP2330979A1 (en) | Apparatus, system, and method for ultrasound powered neurotelemetry | |
| CN108272447A (en) | A kind of breathing and HR Heart Rate detecting system based on UWB technology | |
| US20060094937A1 (en) | Monitoring apparatus of arterial pulses and method for the same | |
| US20220287577A1 (en) | Environmental state health assessment | |
| CN108852341B (en) | A digital wireless neural electrophysiological signal detection single chip, system and method | |
| WO2016187039A1 (en) | Implantable hub and satellite system for neural recording and stimulation | |
| Ryait et al. | Interpretations of wrist/grip operations from SEMG signals at different locations on arm | |
| CN201847678U (en) | Waist belt type wireless heart rate detection device | |
| Selamat et al. | A novel peak detection algorithm using particle swarm optimization for chew count estimation of a contactless chewing detection | |
| Rothfuss et al. | Automatic early-onset free flap failure detection for implantable biomedical devices | |
| CN115444433A (en) | An epilepsy detection device based on EEG signals | |
| WO2004084722A1 (en) | Method and apparatus for for identifying features in an ecg signal | |
| CN105167759A (en) | Human pulse wave velocity measuring method and system based on intelligent mobile phone | |
| Houser et al. | Cetacean evoked potential audiometry by stranding networks enables more rapid accumulation of hearing information in stranded odontocetes | |
| EP1935333B1 (en) | Non-contact apparatus for monitoring cardiopulmonary activity signals and method for the same | |
| EP3606435A1 (en) | Urine turbidity monitoring |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 18840721 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 18840721 Country of ref document: EP Kind code of ref document: A1 |